Allied Biotech (ROCO:1780) Ending Cash Position : NT$618.5 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Allied Biotech Ending Cash Position?

Allied Biotech's Ending Cash Position for the quarter that ended in Dec. 2023 was NT$618.5 Mil.

Allied Biotech's quarterly Ending Cash Position increased from Dec. 2022 (NT$679.8 Mil) to Jun. 2023 (NT$716.4 Mil) but then declined from Jun. 2023 (NT$716.4 Mil) to Dec. 2023 (NT$618.5 Mil).

Allied Biotech's annual Ending Cash Position declined from Dec. 2021 (NT$757.4 Mil) to Dec. 2022 (NT$679.8 Mil) and declined from Dec. 2022 (NT$679.8 Mil) to Dec. 2023 (NT$618.5 Mil).

Allied Biotech Ending Cash Position Historical Data

The historical data trend for Allied Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Biotech Ending Cash Position Chart

Allied Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

408.79

703.48

757.39

679.75

618.49

Allied Biotech Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															757.39	777.94	679.75	716.37	618.49

Allied Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Allied Biotech's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	679.75	+	-61.256
	=	618.5

Allied Biotech's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	716.372	+	-97.878
	=	618.5

Allied Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Allied Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Allied Biotech (ROCO:1780) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Biotech Corp (ROCO:1780) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 76 Tun Hua S. Road, Sec. 2, 12th Floor, Taipei, TWN

Website

http://www.altratene.com

Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.

Allied Biotech (ROCO:1780) Headlines

No Headlines